NAOV NanoVibronix Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NAOV

Price (delayed)

$0.712

Market cap

$1.98M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.12

Enterprise value

-$1.3M

NanoVibronix, Inc. is a medical device company headquartered in Elmsford, New York, with research and development in Nesher, Israel, focused on developing medical devices utilizing its patented low intensity surface ...

Highlights
NanoVibronix's revenue has soared by 127% from the previous quarter
NAOV's debt has dropped by 94% year-on-year and by 74% since the previous quarter
NanoVibronix's quick ratio has increased by 25% YoY but it has decreased by 8% from the previous quarter
The equity has increased by 23% YoY but it has decreased by 15% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.nanovibronix.com
Peers: OBIO OM

Key stats

What are the main financial stats of NAOV
Market
Shares outstanding
2.78M
Market cap
$1.98M
Enterprise value
-$1.3M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.37
Price to sales (P/S)
0.55
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.57
Earnings
Revenue
$2.28M
EBIT
-$3.44M
EBITDA
-$3.44M
Free cash flow
-$3.6M
Per share
EPS
-$2.12
Free cash flow per share
-$2.06
Book value per share
$1.95
Revenue per share
$1.3
TBVPS
$3.81
Balance sheet
Total assets
$6.67M
Total liabilities
$2.69M
Debt
$5,000
Equity
$3.99M
Working capital
$4.03M
Liquidity
Debt to equity
0
Current ratio
2.64
Quick ratio
1.47
Net debt/EBITDA
0.95
Margins
EBITDA margin
-150.5%
Gross margin
67.3%
Net margin
-162.5%
Operating margin
-150.5%
Efficiency
Return on assets
-65.5%
Return on equity
-123.2%
Return on invested capital
-308.6%
Return on capital employed
-81.4%
Return on sales
-150.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NAOV stock price

How has the NanoVibronix stock price performed over time
Intraday
-1.11%
1 week
-5.07%
1 month
-20.89%
1 year
-81.74%
YTD
-38.09%
QTD
-20.89%

Financial performance

How have NanoVibronix's revenue and profit performed over time
Revenue
$2.28M
Gross profit
$1.54M
Operating income
-$3.44M
Net income
-$3.71M
Gross margin
67.3%
Net margin
-162.5%
NanoVibronix's revenue has soared by 127% from the previous quarter
NAOV's net margin has surged by 78% year-on-year and by 67% since the previous quarter
NAOV's operating margin has soared by 77% YoY and by 66% QoQ
NanoVibronix's gross margin has increased by 35% from the previous quarter

Growth

What is NanoVibronix's growth rate over time

Valuation

What is NanoVibronix stock price valuation
P/E
N/A
P/B
0.37
P/S
0.55
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.57
NanoVibronix's EPS has increased by 45% YoY and by 33% from the previous quarter
NAOV's P/B is 92% below its 5-year quarterly average of 4.9 and 82% below its last 4 quarters average of 2.1
The equity has increased by 23% YoY but it has decreased by 15% from the previous quarter
NanoVibronix's revenue has soared by 127% from the previous quarter
The P/S is 97% below the 5-year quarterly average of 21.1 and 89% below the last 4 quarters average of 5.0

Efficiency

How efficient is NanoVibronix business performance
NanoVibronix's ROS has soared by 77% YoY and by 66% from the previous quarter
NanoVibronix's ROIC has soared by 57% YoY and by 23% from the previous quarter
The ROE is up by 30% since the previous quarter and by 11% year-on-year
The ROA has grown by 28% from the previous quarter and by 24% YoY

Dividends

What is NAOV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NAOV.

Financial health

How did NanoVibronix financials performed over time
NanoVibronix's total assets is 148% more than its total liabilities
NanoVibronix's quick ratio has increased by 25% YoY but it has decreased by 8% from the previous quarter
NanoVibronix's total assets has increased by 14% YoY but it has decreased by 9% from the previous quarter
NAOV's debt is 100% smaller than its equity
NAOV's debt to equity has dropped by 100% year-on-year
NAOV's debt has dropped by 94% year-on-year and by 74% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.